Rising prevalence of cardiovascular diseases and rapid advancements in minimally invasive procedures are fueling the growth ...

Kirkland-based heart care company Cardiac Dimensions on Thursday raised a $53 million Series E round.

Out-of-hospital mortality before 30 days was 1.2%, with roughly two-thirds of these patients dying from cardiovascular causes ...

Doctors at Duke Health have successfully performed the world’s first living mitral valve replacement, saving three lives in North Carolina.

Researchers have shed new light on how a type of heart valve disease -- aortic valve stenosis -- progresses differently in males and females.

Cardiac Dimensions has secured $53m in a Series E funding round to support its ongoing pivotal trial assessing the company’s ...

Cardiac Dimensions announced today that it closed an oversubscribed Series E financing round worth $53 million.

Growing investments in healthcare infrastructure and advancements in medical research facilities are driving the expansion of ...

Partial heart transplants provide a range of lifesaving options for children with complex congenital heart conditions, and ...

CMS has approved Medicare and Medicaid coverage for transcatheter tricuspid valve replacement procedures for the treatment of ...

Dr Rajneesh Kapoor highlights the evolution of structural heart disease treatments, exploring the impact of transcatheter ...

Laplace Interventional, a US-based medical device company focusing on transcatheter valve technology, recently announced the ...